DRUG CLASSES & DRUG NOMENCLATURE

1. LEVEL TWO: DESCRIBES THE DRUG'S THERAPEUTIC EFFECT

2. USP DRUG CLASSIFICATION

3. DRUG CLASSES

3.1. DRUG INTERACTIONS

3.2. DRUG RESISTANCE

3.3. TREATMENT STAGING

3.4. ATC CLASSIFICATION SYSTEM

3.4.1. LEVEL THREE: DESCRIBES THE MECHANISM/MODE OF ACTION

3.4.2. LEVEL ONE : DESCRIBES THE ORGAN SYSTEM THE DRUG TREATS

3.4.3. LEVEL FOUR: DESCRIBES THE GENERAL CHEMICAL PROPERTIES OF THE DRUG

3.4.4. LEVEL FIVE: DESCIRBES THE CHEMICAL COMPONENTS THAT MAKE UP DRUUG

3.5. ANALGESICS

3.6. ANESTHETICS

3.7. ANTIBACTERIALS

3.8. ANTICOAVULSANTS

3.9. ANTIDEMENTIA

3.10. ANTIDEPRESSANTS

3.11. ANTIDOTES

3.12. BLOOD GLUCOSE REGULATORS

3.13. BIPOLAR AGENTS

3.14. DENTAL AND ORAL AGENTS

3.15. ENZYME REPLACEMENT AGENT

3.16. GENITOURINARY

3.17. HORMONAL AGENTS

3.18. IMMUNOLIGACAL AGENTS

3.19. OPTHALMIC

3.20. REPISRATORY TRACT AGENTS

3.21. SEDATIVES

3.22. SKELETAL MUSCLE RELAXANTTS

3.23. THERAPEUTIC NUTRIENTS

4. DRUG NAMING NOMENCLATURE

4.1. -O-: NEALRY 100% MOUSE SOURCE FOR THE ANTIBODY STRUCTURE

4.2. -XI-: ANTIBODIES THAT ARE PARTIALLY HUMAN-LIKE AND PARTIALLY OTHER ORGANISM- LIKE IN STRUCTURE

4.3. -ZU-: ANTIBODIES THAT ARE HUMANIZED, OR APPROXIMATELY 90% HUMAN-LIKE

5. SYLLABLE OF TARGET CLASS

5.1. -TU- OR -TUM-: DRUGS USED TO TREAT CANCER

5.2. -LI-: DRUGS THAT IMPACT THE IMMUNE SYSTEM

5.3. -CI-: DRUGS THAT AFFECT THE CIRCULATORY OR CARDIOVASCULAR SYSTEM